Moderator: Alan Vivas, -, Market Access Director, Abbott LATAM, Bogotá, FL, Colombia
Speakers: Fabio Aristizábal, PhD, Director, Biotechnology Institute, National University of Colombia, Bogotá,DC, Colombia; Zoltán Kaló, PhD, Professor of Health Economics, Semmelweis University and Syreon Research Institute, Budapest, Hungary
Limited healthcare resources across many Latin American countries mean that important biologics for conditions such as oncology and orphan drugs are being underutilized, due largely to healthcare system development, economic constraints and limited access to these therapies. These factors contribute to restricted patients access and inequality of healthcare across the region. Payers are increasingly looking for new solutions to help curb healthcare expenditure and broaden patient access. The use of biosimilars has resolved many of these problems in many countries (mainly European and other developed countries) through biosimilars access. The panel will present the understanding of biosimilars, overview of biosimilars reimbursement globally and overview of biosimilars challenges and opportunities in Latin America. Furthermore, they also will discuss how the healthcare system can best adopt the reimbursement policies in Latin America.